Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 64 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard translation Clear all

Conditions: Posttraumatic Stress Disorder
Interventions: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) augmented with Socialization (S); Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 10 Years to 15 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Prostate Cancer
Interventions: Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI); Other
Lead sponsor: University of California, San Diego; Other
Eligibility: Male only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Physical Inactivity, Vascular Dysfunction, Skeletal Muscle Atrophy
Interventions: Sauna, Reduced Physical Activity; Device · Behavioral
Lead sponsor: Brigham Young University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Provo, Utah

Conditions: Endometrial Cancer
Interventions: Ketogenic Diet (KD), Standard Diet (SD); Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 8
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Problem Behavior
Interventions: Progressive Ratio Training (PRT), Differential Reinforcement of Alternative (DRA) Behavior with Extinction; Behavioral
Lead sponsor: Oakland University; Other
Eligibility: 6 Years to 21 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Auburn, Alabama • Rochester, Michigan

Conditions: Dietary Protein
Interventions: Dietary protein shake; Dietary Supplement
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: HIV/AIDS
Interventions: WELL Program; Behavioral
Lead sponsor: Louisiana State University Health Sciences Center in New Orleans; Other
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Heart Failure, Coronary Artery Disease, Ischemic Cardiomyopathy
Interventions: Advanced cardiac imaging, Standard Cardiac Imaging; Other
Lead sponsor: Ottawa Heart Institute Research Corporation; Other
Eligibility: 18 Years and older
Enrollment: 1,390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neurocognition
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Concussion, Brain
Interventions: [11C] PiB, [18F] PBR111, [18F] Flortaucipir; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 70 Years · Male only
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 3
States / cities: Waltham, Massachusetts • Chapel Hill, North Carolina • Milwaukee, Wisconsin

Conditions: Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Interventions: High-dose Methotrexate; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 7 Years to 22 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 9
States / cities: Chapel Hill, North Carolina • Charlotte, North Carolina • Durham, North Carolina + 5 more

Conditions: Severe Malaria, Thrombocytopenia
Interventions: Whole blood transfusion; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 1 Month to 59 Months
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bone Marrow Failure Disorders, VEXAS Syndrome, Hemoglobinurea, Paroxysmal, Myelodysplastic Syndromes, Bone Marrow Diseases
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 2 Years to 120 Years
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cancer, Inflammatory Disease, Vascular Diseases, Metabolic Bone Disease
Interventions: PHOTON COUNTING CT Scanner; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pregnancy Related
Interventions: Exercise in Pregnancy; Behavioral
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Triple Negative Breast Cancer
Interventions: Needle core biopsies, Needle core biopsies of metastatic lesion; Procedure
Lead sponsor: Jewish General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Glioma
Interventions: M032; Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 36 Months and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Cancer, Invasive Breast Cancer, Carcinoma in Situ of the Breast
Interventions: Tissue Sample collection, Blood Sample Collection, Rectal Swab; Procedure · Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cutaneous Melanoma, Melanoma
Interventions: Sentinel Lymph Node Biopsy, Ultrasonography, Sonazoid; Procedure · Device · Drug
Lead sponsor: University of Southern California; Other
Eligibility: 19 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Limited English Proficiency, Perioperative Care
Interventions: Extended translation, Standard translation; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pancreas Cancer, Pancreas Adenocarcinoma
Interventions: Capecitabine; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Disease
Interventions: Ga-68 Galmydar, 13N-ammonia; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Major Depressive Disorder
Interventions: Delta-beta cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MC, Single-session behavioral activation, Active sham cross-frequency transcranial alternating current stimulation via the NeuroConn DC-STIMULATOR MC; Device · Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Autism Spectrum Disorders
Interventions: Patient Navigation; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 16 Months to 32 Months
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado

Search by objective public record fields.

Resilient Roots: Supporting Youth and Families

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Heat Therapy During Reduced Physical Activity

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis

Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling

HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions

IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)

Translational Research Evaluating Neurocognitive Memory Processes

NFL LONG Prospective Study

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study

Translational Development of Photon-counting CT Imaging

Community Translation of the Expecting Study

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Prospective Breast Cancer Biospecimen Collection

Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

Translating Anesthesia Care Throughout

CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Myocardial Perfusion Imaging Galmydar Rest/Stress

Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression

Screening and Linkage to Services for Autism